Insights

Global Market Presence Seegene's extensive international footprint with eight overseas entities and a majority of revenue generated outside Korea indicates strong global demand for its molecular diagnostics products, presenting opportunities to expand distribution channels and develop region-specific solutions.

Innovative Automation The launch of the world's first unattended PCR automation and full automation systems like CURECA demonstrates Seegene's leadership in automation technology, offering prospects for selling advanced diagnostic platforms to laboratories seeking to improve efficiency and reduce labor costs.

Expanding Product Portfolio With over 250 molecular diagnostic reagent kits and new platforms such as STAgora and CURECA, Seegene's diverse and innovative offerings create opportunities to cross-sell comprehensive diagnostic solutions across various infectious diseases and clinical applications.

Research and Partnership Initiatives Seegene's active participation in global scientific awards and open innovation programs signals a focus on collaborative growth and cutting-edge R&D, opening doors for strategic partnerships and co-development opportunities with healthcare providers and research institutions.

Financial Growth Potential Despite current revenue estimates between 250 and 500 million dollars, Seegene's focus on platform transformation and innovation positions it well for accelerated growth and increased sales in the expanding global molecular diagnostics market, especially in diagnostics automation and digital analytics.

(주)씨젠 Tech Stack

(주)씨젠 uses 8 technology products and services including Google Hosted Libraries, Microsoft 365, Swiper, and more. Explore (주)씨젠's tech stack below.

  • Google Hosted Libraries
    Content Delivery Network
  • Microsoft 365
    Email
  • Swiper
    Javascript Libraries
  • AOS
    Javascript Libraries
  • Ubuntu
    Operating Systems
  • HSTS
    Security
  • MUI
    UI Frameworks
  • Google Analytics
    Web Analytics

Media & News

(주)씨젠's Email Address Formats

(주)씨젠 uses at least 1 format(s):
(주)씨젠 Email FormatsExamplePercentage
First.Last@seegene.comJohn.Doe@seegene.com
44%
FLast@seegene.comJDoe@seegene.com
30%
FMLast@seegene.comJMDoe@seegene.com
15%
FirstLast@seegene.comJohnDoe@seegene.com
11%

Frequently Asked Questions

What is (주)씨젠's phone number?

Minus sign iconPlus sign icon
You can contact (주)씨젠's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is (주)씨젠's official website and social media links?

Minus sign iconPlus sign icon
(주)씨젠's official website is seegene.com and has social profiles on LinkedIn.

What is (주)씨젠's SIC code NAICS code?

Minus sign iconPlus sign icon
(주)씨젠's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does (주)씨젠 have currently?

Minus sign iconPlus sign icon
As of December 2025, (주)씨젠 has approximately 1K employees across 5 continents, including North AmericaAsiaEurope. Key team members include Chief People And Culture Officer: D. Y. K.Vice President Of Purchasing: Y. W. K. 김.Vp Of Global Buisiness: J. Y. H.. Explore (주)씨젠's employee directory with LeadIQ.

What industry does (주)씨젠 belong to?

Minus sign iconPlus sign icon
(주)씨젠 operates in the Biotechnology Research industry.

What technology does (주)씨젠 use?

Minus sign iconPlus sign icon
(주)씨젠's tech stack includes Google Hosted LibrariesMicrosoft 365SwiperAOSUbuntuHSTSMUIGoogle Analytics.

What is (주)씨젠's email format?

Minus sign iconPlus sign icon
(주)씨젠's email format typically follows the pattern of First.Last@seegene.com. Find more (주)씨젠 email formats with LeadIQ.

When was (주)씨젠 founded?

Minus sign iconPlus sign icon
(주)씨젠 was founded in 2000.

(주)씨젠

Biotechnology ResearchSeoul, South Korea1001-5000 Employees

[INTRODUCING OUR COMPANY]
The people of Seegene are on a purposeful mission to improve the world we live in. We aim to improve the quality of life for everyone globally by bringing molecular diagnostics to the masses.

Molecular diagnostics is the most effective method to accurately diagnose ailments and is also the best way to diagnose them early which is when you can make the most difference in the recovery treatment.

With industry-leading IP in molecular diagnostics reagent assays, we are dedicated to leveraging our unique technologies to increase our product portfolio, expand our market coverage, and lowering the total cost to serve our customers so that molecular diagnostics become a part of the fabric of everyone’s life and thus, improving the quality of life for everyone in the world.


[OUR HISTORY AND OUR FUTURE]
Since our founding in 2000, we have been steadfastly focused on molecular diagnostics.
Currently, our product portfolio consists of over 250 molecular diagnostics reagent kits as well as a wide range of instruments and consumables that are sold globally.

Testament to our expertise, when the pandemic started, Seegene was one of the first companies in the world to provide testing kits that were crucial in the fight against COVID.

Today, we are a company with revenue of over $1 billion dollars and 65% gross margins. With 8 overseas entities, we generate a majority of our revenue outside of Korea.

In keeping with our spirit of innovation and making a difference in the world, there are many exciting innovations being worked on at Seegene which will make it easier for the world to access the benefits of molecular diagnostics.

We are transforming our business from a discrete reagent assay and instruments business to a platform business that will create new markets for molecular diagnostics and improve the quality of life for everyone. We hope that you will join us in our mission to make a meaningful difference in the world.

Section iconCompany Overview

Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2000
Employees
1001-5000

Section iconFunding & Financials

  • $250M$500M

    (주)씨젠's revenue is estimated to be in the range of $250M$500M

Section iconFunding & Financials

  • $250M$500M

    (주)씨젠's revenue is estimated to be in the range of $250M$500M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.